According to latest market report, the global oral thin films market value reached at US$ 2.8 Bn in 2020 and projected to reach US$ 6.5 billion by 2030.
The oral thin films market growth is expanding at a noteworthy CAGR of 9.1% from 2021 to 2030. Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa. Rise in demand for thin film drug delivery systems, considerable research & development, and strategic alliances between novel technology owners and large pharmaceutical companies are major factors that are anticipated to drive the global oral thin films market during the forecast period.
Rising Demand for Thin Film Drug Delivery System to Drive Market
The demand for thin film drug delivery system is rising due to benefits such as larger surface area, precision medication, and pleasant color & flavor over traditional drug delivery systems. Thin film drugs are reported to be the preferred choice of patients as well as medical practitioners, as they are more patient-friendly and offer good quality results. Oral thin film drugs offer high compliance to patients, and ease of storage and transportation. Moreover, these offer precise and accurate dosing with the desired effective outcome. Hence, the thin film drug delivery system market has recorded substantial attractiveness. High acceptance level and impressive advantages have further propelled the global oral thin film market.
Elongation at Break, Tear Resistance Form Important Factors for Manufacturing
Fast wetting, disintegration, and dissolution with large surface areas of oral thin films are translating into incremental opportunities for pharmaceutical companies. They are leveraging business opportunities to manage schizophrenia and migraine, since neurological conditions are estimated to dominate the highest revenue among all indication types in oral thin films market during the assessment period.
The oral thin films market is projected to advance at a robust CAGR of 9.1% during the forecast period. Manufacturers are keeping in mind mechanical properties of drug eluting oral thin films, such as elongation at break and tear resistance, which are important factors for manufacturing, handling, and transportation. Companies are aiming to achieve precise dosing and flexibility in oral thin films so that they can be perforated and manipulated in size and thickness for the delivery of highly uniformed doses.
Multiple Polymer-based Layers Overcome Thin Film Shortcomings
The oral thin films market is projected to reach the value of US$ 6.5 Bn by the end of 2030. However, it has been found that the small size of oral thin films leads to limited drug load capacities as compared to tablets and capsules. Hence, manufacturers are innovating in single and multiple polymer-based layers with the intended form of APIs (Active Pharmaceutical Ingredients).
On the other hand, manufacturers in the oral thin films market are faced with common misconceptions that these films can only carry aqueous soluble drugs. On the contrary, there are demonstrations that show the incorporation of poorly water soluble BCS II/IV drugs into orally disintegrating films that dissolve in the gastrointestinal (GI) tract.
In terms of product, the global oral thin films market has been classified into sublingual film, fast dissolving oral film, and buccal film. The sublingual film segment dominated the global oral thin films market in 2020, and the trend is projected to continue during the forecast period. Significant research activities, strong product pipeline, and high market adoption of sublingual film are expected to boost the segment during the forecast period.
In terms of indication, the global oral thin films market has been categorized into pain management, neurological disorders, nausea & vomiting, opioid dependence, and others. The neurological disorders segment held a major share of the global oral thin films market in 2020. Rise in prevalence of neurological disorders is expected to drive the segment during the forecast period. According to the data published by the National Center for Biotechnology Information, the mean prevalence of neurological disorders was around 2,394 per 100,000 population in India.
Based on distribution channel, the global oral thin films market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the market in 2020, owing to higher preference for retail pharmacies among end users, easy availability of a wide range of products, and increase in the number of retail pharmacies in developing countries.
North America is projected to account for a leading share of the global oral thin films market during the forecast period. Higher penetration of oral thin films, availability of the products, and presence of a large number of suppliers compared to other regions are the major factors driving the market in the region.
The market in Asia Pacific is expected to expand at a high CAGR in the near future, owing to the presence of local as well as global players and an increase in the demand for oral thin films in the region. The oral thin films market in Europe is likely to expand at a rapid pace in the near future. Japan and China are anticipated to be lucrative markets for oral thin films during the forecast period. Presence of large geriatric patient population with dysphagia and increase in healthcare expenditure in these countries are projected to propel the market in Asia Pacific over the next few years.
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.
The analysts have provided a comprehensive analysis of the competitive landscape of the global oral thin films market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.
Key players operating in the global oral thin films market are ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt. Ltd., Shilpa Therapeutics Pvt. Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp., Dr. Reddy's Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo, and C.L. Pharm. These companies engage in research & development to develop novel products in order to expand product offerings and customer base. In January 2021, Cure Pharmaceutical received the U.S. FDA approval for CUREfilm Blue for the treatment of erectile dysfunction (ED). It increased the commercial opportunity for Cure Pharmaceutical in the U.S.
This report focuses on oral thin films market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall oral thin films market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global oral thin films market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global oral thin films market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the oral thin films market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
In this study, the years considered to estimate the market size of oral thin films are as follows:
The research methodology adopted by analysts for compiling the global oral thin films market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global oral thin films market.
The study objectives of this report are: